Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $7.2 million.

  • Upstream Bio's Accumulated Expenses rose 3668.11% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 3668.11%. This contributed to the annual value of $6.0 million for FY2024, which is 3375.0% up from last year.
  • As of Q3 2025, Upstream Bio's Accumulated Expenses stood at $7.2 million, which was up 3668.11% from $7.7 million recorded in Q2 2025.
  • Upstream Bio's 5-year Accumulated Expenses high stood at $7.7 million for Q2 2025, and its period low was $4.1 million during Q1 2025.
  • For the 3-year period, Upstream Bio's Accumulated Expenses averaged around $5.8 million, with its median value being $5.6 million (2024).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 3375.0% in 2024, then soared by 3668.11% in 2025.
  • Over the past 3 years, Upstream Bio's Accumulated Expenses (Quarter) stood at $4.5 million in 2023, then soared by 33.75% to $6.0 million in 2024, then increased by 20.83% to $7.2 million in 2025.
  • Its Accumulated Expenses stands at $7.2 million for Q3 2025, versus $7.7 million for Q2 2025 and $4.1 million for Q1 2025.